Ignac Fogelman

Q: What Schools Are Affiliated With Ignac Fogelman

Ignac Fogelman is affiliated with the following schools: King's College London, University of Kent

Ignac Fogelman's AcademicInfluence.com Rankings

Ignac Fogelman

Philosophy

#4392

World Rank

#6886

Historical Rank

Logic

#1857

World Rank

#2712

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ignac Fogelman's Degrees

PhD Medicine University of Oxford

Why Is Ignac Fogelman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ignac Fogelman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. (2001) (1551)
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene (1996) (641)
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. (1998) (517)
Primer on the metabolic bone diseases and disorders of mineral metabolism (2003) (437)
The role of DXA bone density scans in the diagnosis and treatment of osteoporosis (2007) (378)
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. (1996) (375)
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update (1998) (337)
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. (2002) (334)
Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. (2001) (281)
Technical principles of dual energy x-ray absorptiometry. (1997) (262)
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. (2004) (257)
Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine (1999) (252)
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. (1997) (248)
Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group. (2000) (230)
Positron emission tomography and bone metastases. (2005) (219)
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. (1978) (212)
Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women (1995) (211)
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis (1992) (200)
Management of male osteoporosis: report of the UK Consensus Group. (1998) (194)
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. (2006) (192)
FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE (1984) (187)
The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate (2010) (179)
The value of SPECT scans in identifying back pain likely to benefit from facet joint injection. (1996) (177)
Bone scan flare predicts successful systemic therapy for bone metastases. (1988) (176)
DIPHOSPHONATES AND INHIBITION OF BONE MINERALISATION (1982) (173)
Can the WHO Criteria for Diagnosing Osteoporosis be Applied to Calcaneal Quantitative Ultrasound? (2000) (171)
HYPERCALCAEMIC OSTEOMALACIA DUE TO ALUMINIUM TOXICITY (1982) (166)
Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis. (2007) (162)
The evaluation of osteoporosis : dual energy x-ray absorptiometry and ultrasound in clinical practice (1999) (157)
Visual Assessment of Vertebral Deformity by X-ray Absorptiometry: A Highly Predictive Method to Exclude Vertebral Deformity (2000) (155)
Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women. (1990) (151)
The evaluation of osteoporosis : dual energy x-ray absorptiometry in clinical practice (1994) (150)
Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness (2012) (150)
The role of positron emission tomography in the management of bone metastases (2000) (149)
Quantitative Ultrasound and Bone Mineral Density Are Equally Strongly Associated with Risk Factors for Osteoporosis (2001) (149)
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. (2003) (137)
Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss (2004) (134)
Extra-articular features of benign joint hypermobility syndrome. (1996) (133)
Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. (2004) (125)
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group. (2000) (123)
Different approaches to bone densitometry. (2000) (122)
The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT (2010) (120)
ABSORPTION OF ORAL DIPHOSPHONATE IN NORMAL SUBJECTS (1986) (120)
The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. (2013) (119)
Prostate cancer: role of SPECT and PET in imaging bone metastases. (2009) (115)
A clinical profile of back pain and disability in patients with spinal osteoporosis. (1994) (113)
Long-Term Precision of DXA Scanning Assessed over Seven Years in Forty Postmenopausal Women (2000) (113)
An update on dual-energy x-ray absorptiometry. (2010) (112)
Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density. (2016) (111)
Multisite Quantitative Ultrasound: Precision, Age- and Menopause-Related Changes, Fracture Discrimination, and T-score Equivalence with Dual-Energy X-ray Absorptiometry (2001) (109)
Screening for Osteopenia and Osteoporosis: Do the Accepted Normal Ranges Lead to Overdiagnosis? (1997) (109)
18F-NaF PET/CT: EANM procedure guidelines for bone imaging (2015) (107)
The role of positron emission tomography in skeletal disease. (2001) (103)
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates? (2007) (101)
Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) (2003) (101)
Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy. (1989) (101)
The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT (2009) (98)
Quantification of Skeletal Kinetic Indices in Paget's Disease Using Dynamic18F‐Fluoride Positron Emission Tomography (2002) (98)
Reversible bone loss in anorexia nervosa. (1987) (96)
Relationship of Calcification of Atherosclerotic Plaque and Arterial Stiffness to Bone Mineral Density and Osteoprotegerin in Postmenopausal Women Referred for Osteoporosis Screening (2008) (94)
The clinical role of dual energy X-ray absorptiometry. (2009) (94)
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. (2003) (92)
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease (2010) (89)
Reappraisal of the baseline bone scan in breast cancer. (1988) (88)
Morphometric X‐Ray Absorptiometry and Morphometric Radiography of the Spine: A Comparison of Prevalent Vertebral Deformity Identification (2000) (88)
Patient dose in dual x-ray absorptiometry (2006) (87)
Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. (2009) (87)
Biochemical prediction of response of bone metastases to treatment. (1988) (87)
A comparison of bone mineral density in the spine, hip and jaws of edentulous subjects. (2007) (86)
Contact Quantitative Ultrasound: An Evaluation of Precision, Fracture Discrimination, Age-Related Bone Loss and Applicability of the WHO Criteria (1999) (85)
Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. (1988) (85)
Risedronate Reduces the Risk of First Vertebral Fracture in Osteoporotic Women (2002) (83)
Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. (1998) (82)
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women. (2004) (82)
Bone Scanning in Clinical Practice (2012) (80)
The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study. (1997) (80)
Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions (1999) (78)
The Effect of Season and Vitamin D Supplementation on Bone Mineral Density in Healthy Women: A Double-Masked Crossover Study (2001) (78)
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. (1984) (78)
SPECT/CT in imaging foot and ankle pathology-the demise of other coregistration techniques. (2010) (77)
The role of bone scanning in osteomalacia. (1978) (77)
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. (1984) (76)
Fluorine-18-FDG PET in Paget's disease of bone. (1997) (74)
F-18 FDG Positron Emission Tomography and Benign Fractures (2003) (73)
Vitamin D and bone mineral density (2007) (73)
Differences in Skeletal Kinetics Between Vertebral and Humeral Bone Measured by 18F‐Fluoride Positron Emission Tomography in Postmenopausal Women (2000) (73)
Dual energy x-ray absorptiometry: the effects of beam hardening on bone density measurements. (1992) (72)
Bone mineral content of women receiving tamoxifen for mastalgia. (1989) (71)
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? (2001) (71)
Obesity increases precision errors in dual-energy X-ray absorptiometry measurements. (2012) (71)
A study of the effect of tibolone on the vagina in postmenopausal women. (1994) (71)
Chronic low back pain: comparison of bone SPECT with radiography and CT. (1992) (71)
Bone secondaries in breast cancer: the solitary metastasis. (1989) (71)
Interpretation of bone densitometry studies. (1997) (70)
Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA. (2009) (70)
Fractal signature analysis of macroradiographs measures trabecular organization in lumbar vertebrae of postmenopausal women (1994) (70)
Bone scanning in clinical oncology: does it have a future? (1998) (70)
The bone scan: where are we now? (1995) (69)
Multislice SPECT/CT in benign and malignant bone disease: when the ordinary turns into the extraordinary. (2009) (68)
Vertebral morphometry studies using dual-energy x-ray absorptiometry. (1997) (68)
Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism (2008) (68)
Differential effects of teriparatide on regional bone formation using 18F‐fluoride positron emission tomography (2011) (68)
The role of nuclear medicine in monitoring treatment in skeletal malignancy. (2001) (67)
Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial (2003) (66)
Can the WHO definition of osteoporosis be applied to multi-site axial transmission quantitative ultrasound? (2004) (66)
How Important Are BMD Accuracy Errors for the Clinical Interpretation of DXA Scans? (2007) (65)
Dissociation Between Global Markers of Bone Formation and Direct Measurement of Spinal Bone Formation in Osteoporosis (2004) (65)
COLIA1 Sp1 Polymorphism Predicts Response of Femoral Neck Bone Density to Cyclical Etidronate Therapy (2002) (65)
BONE MASS IN HIRSUTE WOMEN WITH ANDROGEN EXCESS (1989) (65)
Morphometric X‐Ray Absorptiometry: Reference Data for Vertebral Dimensions (1998) (64)
Bone Mineral Density and Its Relationship to Prolactin Levels in Patients Taking Antipsychotic Treatment (2005) (64)
SKELETAL UPTAKE OF DIPHOSPHONATE Method for Prediction of Post-menopausal Osteoporosis (1980) (64)
Osteoporosis and chronic back pain: A study with single‐photon emission computed tomography bone scintigraphy (1992) (64)
Treatment of post-menopausal osteoporosis: beyond bisphosphonates (2014) (63)
Osteocalcin: a potential marker of metastatic bone disease and response to treatment. (1988) (62)
Radionuclide and Hybrid Bone Imaging (2012) (62)
Skeletal metastases from breast cancer: imaging with nuclear medicine. (1999) (62)
Applications of bone densitometry for osteoporosis. (1998) (60)
The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. (1990) (58)
The effect of positioning on dual energy X-ray bone densitometry of the proximal femur. (1991) (57)
Erratum to: The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT (2010) (57)
Skeletal uptake of diphosphonate: A review (1980) (57)
Bone scintigraphy in metabolic bone disease. (1997) (55)
Ultrasonic velocity measurements through the calcaneus: Which velocity should be measured? (2005) (54)
Skeletal Nuclear Medicine (1996) (54)
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis (2007) (53)
Too much heparin: possible source of error in blood gas analysis. (1983) (53)
Peripheral or central densitometry: does it matter which technique we use? (2001) (53)
Bone mineral density in professional female dancers. (1997) (52)
99mTc Diphosphonate Uptake Mechanism on Bone (1987) (52)
An Atlas of Clinical Nuclear Medicine (2014) (52)
The value of bone scintigraphy in the evaluation of osteoporotic patients with back pain (2002) (51)
Does the Combination of Two BMD Measurements Improve Fracture Discrimination? (2003) (51)
A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. (1980) (51)
A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip (2002) (50)
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy (2006) (50)
Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans. (1993) (49)
A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. (2003) (49)
Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography. (2001) (49)
FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy (2001) (49)
Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans (1993) (49)
A Prospective Study of Risedronate on Regional Bone Metabolism and Blood Flow at the Lumbar Spine Measured by18F‐Fluoride Positron Emission Tomography (2003) (49)
Long‐Term Effect of Strontium Ranelate Treatment on BMD (2005) (48)
A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. (1981) (48)
FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy (2006) (48)
Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study. (1999) (46)
Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. (1980) (46)
Obesity increases precision errors in total body dual-energy x-ray absorptiometry measurements. (2015) (45)
Bone densitometry: current status and future prospects. (1997) (45)
Quantitative ultrasound: assessment of osteoporosis and bone status. (2000) (45)
[11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. (1998) (45)
Scintigraphic evaluation of the painful prosthetic joint: a comparison of gallium-67 citrate and indium-111 labelled leucocyte imaging. (1984) (44)
Gonadotropin-releasing hormone agonists and the skeleton. (1992) (44)
Dual X-ray absorptiometry of the lumbar spine: the precision of paired anteroposterior/lateral studies. (1994) (44)
Quantitative studies of bone using 18F-fluoride and 99mTc-methylene diphosphonate: evaluation of renal and whole-blood kinetics (2001) (44)
The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. (2015) (44)
Osteopaenia of the lumbar spine and femoral neck in anorexia nervosa. (1986) (44)
Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency. (2013) (44)
HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK? (1982) (43)
Measurement of bone mass. (1992) (43)
Osteoporotic vertebral fractures: diagnosis with radiography and bone scintigraphy. (1994) (42)
Bone densitometry and the diagnosis of osteoporosis. (2001) (42)
Insulin-like growth factor-I and bone mineral density. (1998) (42)
Potential role of multislice SPECT/CT in impingement syndrome and soft-tissue pathology of the ankle and foot (2013) (42)
Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images (2012) (41)
Dual energy x-ray absorptiometry and its clinical applications. (2002) (41)
Comparison of clinical, radionuclide, and radiographic features of osteoarthritis of the hands. (1991) (41)
Conventional measurements of GFR using 51Cr-EDTA overestimate true renal clearance by 10 percent (2002) (41)
A review of strontium ranelate and its effect on DXA scans. (2007) (40)
Rheumatoid arthritis and osteoporosis. (1986) (40)
Morphometric X-ray Absorptiometry and Morphometric Radiography of the Spine: A Comparison of Analysis Precision in Normal and Osteoporotic Subjects (1999) (40)
Bone scintigraphy following intravenous pamidronate for Paget's disease of bone. (1992) (39)
Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). (2011) (39)
Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene (2005) (39)
Bone scintigraphy: Part 2. Orthopedic bone scanning. (1993) (39)
Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: (18)F-fluoride PET study of treatment-naïve and treated postmenopausal women. (2009) (39)
The effect of anorexia nervosa on skin thickness, skin collagen and bone density (1989) (39)
The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods (2011) (39)
Pitfalls and Limitations of Radionuclide Planar and Hybrid Bone Imaging. (2015) (39)
Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication. (1982) (39)
18F‐fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: A prospective, randomized, controlled clinical study (2013) (38)
Intersite comparison of the Hologic QDR-1000 dual energy X-ray bone densitometer. (1991) (38)
Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment (2009) (38)
A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication. (1979) (38)
The identification of spinal pathology in chronic low back pain using single photon emission computed tomography. (1992) (38)
Does Quantitative Ultrasound Imaging Enhance Precision and Discrimination? (2000) (38)
CLINICAL VALUE OF ADRENAL ANDROGEN MEASUREMENT IN THE DIAGNOSIS OF DELAYED PUBERTY (1981) (38)
Postmenopausal screening for osteopenia. (1992) (37)
Total body studies in normal British women using dual energy X-ray absorptiometry. (1993) (37)
Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate. (2002) (37)
Nuclear medicine studies in metabolic bone disease. (2002) (37)
Hormone Binding Globulins and Anticonvulsant Therapy (1985) (37)
Could Strontium Ranelate Have a Synergistic Role in the Treatment of Osteoporosis? (2009) (36)
A comparison of reference bone mineral density measurements derived from two sources: referred and population based. (1993) (36)
Effects of 8 Years of Treatment with Tibolone 2.5 mg Daily on Postmenopausal Bone Loss (2001) (36)
Peripheral or axial bone density measurements? (1998) (36)
The correction of BMD measurements for bone strontium content. (2007) (36)
Radioiodine treatment of solitary functioning thyroid nodules. (1986) (35)
Late Low‐Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral Density (2006) (35)
Additional benefit of SPECT-CT in investigating heel pain. (2008) (35)
An Investigation of Unique and Shared Gene Effects on Speed of Sound and Bone Density Using Axial Transmission Quantitative Ultrasound and DXA in Twins (2003) (35)
Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin. (2003) (35)
Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease (1993) (34)
Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD). (1992) (34)
SPECT bone scintigraphy of anterior cruciate ligament injury. (1996) (34)
A longitudinal study of supine lateral DXA of the lumbar spine: A comparison with posteroanterior spine, hip and total-body DXA (1996) (34)
Occupational dose to the radiographer in dual X-ray absorptiometry: a comparison of pencil-beam and fan-beam systems. (1996) (33)
An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry (2004) (33)
Multisite Quantitative Ultrasound: Colles’ Fracture Discrimination in Postmenopausal Women (2002) (33)
The accuracy of volumetric bone density measurements in dual X-ray absorptiometry (1995) (33)
Imaging of Site Specific Bone Turnover in Osteoporosis Using Positron Emission Tomography (2014) (33)
Quantitative Measurements of Bone Remodeling Using 99mTc-Methylene Diphosphonate Bone Scans and Blood Sampling (2008) (33)
Tamoxifen protects against steroid-induced bone loss. (1992) (33)
A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease (1980) (32)
The role of bone scanning in Paget's disease. (1981) (32)
Optimizing data acquisition and analysis of morphometric X-ray absorptiometry (2007) (31)
Lung scanning for pulmonary embolism: clinical and pulmonary angiographic correlations. (1990) (31)
Quantitative Radionuclide Studies of Bone (2009) (31)
Theoretical Model for the Interpretation of BMD Scans in Patients Stopping Strontium Ranelate Treatment (2006) (31)
Diphosphonate bone scanning agents — Current concepts (2004) (31)
The role of nuclear medicine in orthopaedics (1994) (31)
Aortic distensibility in post-menopausal women receiving Tibolone. (1994) (31)
Strontium ranelate for the treatment of osteoporosis (2005) (30)
The ultrasonic assessment of osteopenia as defined by dual X-ray absorptiometry. (1994) (30)
The role of 99mTc-diphosphonate bone SPECT/CT in the ankle and foot (2012) (30)
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements (2011) (30)
The effect of 1α‐hydroxyvitamin D3 on the mineralization defect in disodium etidronate‐treated paget's disease — a double‐blind randomized clinical study (1987) (29)
Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis. (2002) (29)
Bone scintigraphy: Part 1. Oncology and infection. (1993) (29)
Does the Combination of Quantitative Ultrasound and Dual-Energy X-Ray Absorptiometry Improve Fracture Discrimination? (2001) (29)
Exercise myocardial perfusion scintigraphy with technetium-99m methoxy isobutylisonitrile: a comparative study with thallium-201. (1990) (29)
The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime. (1986) (29)
Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women (2012) (28)
Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. (2018) (28)
A semipopulation input function for quantifying static and dynamic 18F-fluoride PET scans (2012) (28)
Assessment of synthetic steroid (Org OD 14): effect on skeletal metabolism by 24-h whole-body retention of diphosphonate. (1981) (28)
Clinical role of bisphosphonate therapy (2012) (28)
Effect of bone strontium on BMD measurements. (2007) (28)
Nuclear Medicine Annual 2002 (2002) (28)
Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine. (1987) (27)
Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. (1993) (27)
SPECT/CT of Femeroacetabular Impingement (2008) (27)
Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover? (2011) (27)
Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence (2012) (27)
Pregnancy in a woman with premature ovarian failure. (1985) (26)
Techetium 99m methylene diphosphonate bone scanning in osteoarthritic hands (2004) (26)
Measurements of broadband ultrasonic attenuation in the calcaneus in premenopausal and postmenopausal women (1992) (26)
Pseudofracture of the ribs detected by bone scanning. (1977) (26)
18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease (2013) (26)
Combined oral contraception and skeletal bone mass (1987) (25)
Pseudohypoparathyroidism presenting as severe Parkinsonism. (1981) (25)
Bone density in users of combined oral contraception. Preliminary reports of a pilot study. (1991) (25)
Bone scintigraphy: Part 3. Bone scanning in metabolic bone disease. (1993) (25)
Bone densitometry: an update (2005) (25)
Effect of tibolone on postmenopausal bone loss (1994) (25)
Review of 3,530 referrals for bone density measurements of spine and femur: evidence that radiographic osteopenia predicts low bone mass. (1998) (24)
Bone scintigraphy predicts outcome of steroid injection for plantar fasciitis. (2006) (24)
Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer (2016) (24)
Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases. (1988) (24)
The "hot patella" sign: is it of any clinical significance? Concise communication. (1983) (24)
Differences in regional bone metabolism at the spine and hip: a quantitative study using 18F-fluoride positron emission tomography (2013) (24)
Significant differences in UK and US female bone density reference ranges (2010) (24)
The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover. (2007) (24)
The Effect of Weight Change on Total Body Dual-Energy X-ray Absorptiometry: Results from a Clinical Trial (2000) (24)
Recent Advances in Imaging Hepatocellular Carcinoma: Diagnosis, Staging and Response Assessment Functional Imaging (2004) (24)
Autoparathyroidectomy: A case report (1979) (24)
Changes in QUS and BMD Measurements with Antiresorptive Therapy: A Two-Year Longitudinal Study (2001) (23)
Intermittent Oral Disodium Pamidronate in Established Osteoporosis: A 2 Year Double-Masked Placebo-Controlled Study of Efficacy and Safety (2000) (23)
Should broadband ultrasonic attenuation be normalized for the width of the calcaneus? (1994) (22)
Bone density of normal women in relation to endogenous and exogenous oestrogens. (1994) (22)
Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis (2011) (22)
Distribution of bone mineral density in the lumbar spine in health and osteoporosis (1994) (22)
A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease (1981) (22)
Predicting the Risk of Fracture at Any Site in the Skeleton: Are All Bone Mineral Density Measurement Sites Equally Effective? (2005) (22)
A comparison of MRI and bone SPET in the diagnosis of knee pathology (1996) (21)
A study of the early and late 99technetium scintigraphic images and their relationship to symptoms in osteoarthritis of the hands. (1993) (21)
The localization of myocardial ischaemia with technetium-99m methoxy isobutyl isonitrile and single photon emission computed tomography. (1989) (21)
Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism (2012) (21)
Methods and Clinical Issues in Bone Densitometry and Quantitative Ultrasonometry (2002) (21)
Management of the solitary thyroid nodule. (1989) (21)
Osteopetrosis: Radiological & Radionuclide Imaging (2015) (21)
Quantitative PET Imaging Using (18)F Sodium Fluoride in the Assessment of Metabolic Bone Diseases and the Monitoring of Their Response to Therapy. (2012) (21)
The thyroid scan in Hashimoto's thyroiditis: the great mimic (1988) (21)
The Effect of Weight Change on DXA Scans in a 2-Year Trial of Etidronate Therapy (1997) (20)
Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance. (2009) (20)
Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy (2008) (20)
Principles of bone biology Vol 2 (2002) (20)
Scintigraphy of benign bone disease. (2007) (19)
Validation of ultrafiltration as a method of measuring free 99mTc-MDP. (2003) (19)
Peripheral and Central Measurements of Bone Mineral Density Are Equally Strongly Associated with Clinical Risk Factors for Osteoporosis (2007) (18)
Tuberculosis of the Spine on Tc-99m MDP Bone Scan: Additional Role of SPECT-CT (2009) (18)
Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids. (2008) (18)
Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease. (1984) (18)
DXA scanning and its interpretation in osteoporosis. (2003) (18)
Bone scan findings in hypervitaminosis D: case report. (1977) (18)
The Bone Scan in Metastatic Disease (1991) (17)
The relationship between gonadotrophins, gonadal hormones and bone mass in men (2008) (17)
Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT (2012) (17)
Validation of image-derived arterial input functions at the femoral artery using 18F-fluoride positron emission tomography (2011) (16)
Changes in bone mineral density and bone turnover in patients on ‘drug holiday’ following bisphosphonate therapy: real‐life clinic setting (2016) (16)
A LOW DOSE REGIME OF 1α HYDROXYVITAMIN D3 IN THE MANAGEMENT OF SENILE OSTEOPOROSIS: A PILOT STUDY (1980) (16)
Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women. (2002) (16)
A dose-controlled study of Sm-153 -EDTMP in the treatment of patients with painful bone metastases (1997) (16)
Fracture thresholds in osteoporosis: implications for hormone replacement treatment. (1992) (16)
A Method for Determining Skeletal Lengths from DXA Images (2007) (16)
The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancer (1978) (16)
The effects of oestrogen deficiency on the skeleton and its prevention. (1996) (16)
Measurements of postmenopausal bone loss with a new contact ultrasound system (1993) (16)
31. Physiological variants in 18FDG PET scanning: Potential for error in interpretation (1996) (16)
Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication. (1983) (15)
Monitoring treatment for osteoporosis by using bone densitometry. (2001) (15)
Vitamin D Status and Parathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab (2014) (15)
Semi-quantitative interpretation of the bone scan in metabolic bone disease (1979) (15)
Registration Bone Scan in the Evaluation of Wrist Pain (1997) (15)
Selection of patients with breast cancer for routine follow-up bone scans. (1990) (15)
Measurement of forearm bone mineral density in normal women by dual-energy X-ray absorptiometry. (1992) (15)
Registration bone scan in the evaluation of wrist pain. (1993) (15)
Comparison of 10 versus 20 min SPECT 99mTc-MDP bone scans: use of 3D-OSEM image reconstruction with distance-dependent resolution modelling (2010) (15)
The Bone Scan in Clinical Practice (1980) (15)
Bone mineral measurements in clinical practice. (1987) (14)
A comparison of a peripheral DXA system with conventional densitometry of the spine and femur. (1998) (14)
Recognition of the femoroacetabular impingement syndrome on MDP SPECT CT. (2008) (14)
Spinal bone SPECT in chronic symptomatic ankylosing spondylitis. (1997) (14)
Validation of new image-derived arterial input functions at the aorta using 18F-fluoride positron emission tomography (2011) (14)
An evaluation of the contribution of bone mass measurements to clinical practice. (1989) (14)
Post-menopausal vertebral osteoporosis: can dual energy X-ray absorptiometry forearm bone density substitute for axial measurements? (1994) (14)
Bone densitometry, steroids and osteoporosis. (2002) (14)
Atypical Paget's Disease With Quantitative Assessment of Tracer Kinetics (2007) (14)
Goserelin (Zoladex) and the skeleton (1994) (14)
An atlas of planar and SPECT bone scans (1989) (13)
Paget's disease--five years follow up after pamidronate therapy. (1994) (13)
Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera. (1981) (13)
Scintigraphy in metabolic bone disease (2003) (13)
Radionuclide measurement of right ventricular function in atrial septal defect, ventricular septal defect and complete transposition of the great arteries. (1986) (13)
Combined phlebography and arthrography in patients with painful swollen calf. (1981) (13)
Pitfalls and Limitations of Radionuclide Imaging in Endocrinology. (2015) (13)
Fracture Prediction by Bone Density Measurements at Sites Other than the Fracture Site: the Contribution of BMD Correlation (2005) (13)
Serial scintiscanning in breast cancer: the indications and prognostic value. (1980) (13)
DEAFNESS DUE TO HYPERVITAMINOSIS D (1979) (13)
Lateral collateral ligament tear of the knee: appearances on bone scintigraphy with single-photon emission tomography (1996) (12)
Radiation dose to the patient and operator from a peripheral dual X-ray absorptiometry system. (1999) (12)
Bone SPECT in osteoid osteoma of the vertebral lamina. (1994) (12)
Correcting 18F-fluoride PET static scan measurements of skeletal plasma clearance for tracer efflux from bone (2014) (12)
The relationship between pro-resorptive inflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations. (2013) (12)
Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance. (2006) (12)
Absolute fracture risk varies with bone densitometry technique used. A theoretical and in vivo study of fracture cases. (2002) (12)
Tumor hypoxia: the role of nuclear medicine. (1998) (12)
The radiologic diagnosis of osteoporosis (2006) (12)
Whole body retention of diphosphonate in rheumatoid arthritis. (1982) (12)
Clinical use of instruments that measure peripheral bone mass (2002) (12)
Circulating concentrations of vitamin E isomers: Association with bone turnover and arterial stiffness in post-menopausal women. (2015) (12)
Do Anticonvulsant Drugs Commonly Induce Osteomalacia? (1982) (12)
Thyroid hormone and parathyroid hormone competing to maintain calcium levels in the presence of vitamin D deficiency. (2004) (11)
Effect of etidronate disodium on bone turnover following surgical menopause (1989) (11)
Osteonecrosis of the Jaw: More Heat Than Light (2008) (11)
Value of SPECT/CT in the evaluation of knee pain. (2013) (11)
The isotope bone scan: we can do better (2013) (11)
The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study. (1987) (10)
Quantitative Trait Loci for Bone Lengths on Chromosome 5 Using Dual Energy X-Ray Absorptiometry Imaging in the Twins UK Cohort (2008) (10)
Diabetes and bone: advantages and limitations of radiological, radionuclide and hybrid techniques in the assessment of diabetic foot. (2009) (10)
Ablation of mediastinal parathyroid adenomas by superselective embolization of the internal mammary artery with alcohol. (1993) (10)
Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone (2003) (10)
Sacroiliac quantitative bone scintigraphy in ankylosing spondylitis: any clinical relevance? (1993) (10)
Osteoblastic bone metastases in breast cancer: is not seeing believing? (2005) (10)
Bone: Strontium ranelate does not have an anabolic effect on bone (2013) (10)
Effect of subdermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy. (1984) (10)
Diagnosis of infection in the diabetic foot using 18F‐FDG PET/CT: a sweet alternative? (2012) (10)
Bone Scintigraphy: Patterns, Variants, Limitations and Artefacts (2012) (10)
SPECT Imaging in the Diagnosis of Meniscal Tears (1993) (10)
Bone scan appearance of a Paget's osteosarcoma: failure to concentrate HEDP. (1977) (10)
28. Facet joint injection in patients with low back pain and increased facetal joint activity on bone scintigraphy with SPECT: a pilot study (1992) (10)
The role of thyroid scanning in hyperthyroidism (2004) (9)
Oestrogen, the prevention of bone loss and osteoporosis. (1991) (9)
Assessment of skeletal uptake of99mTc-diphosphonate over a five day period (2004) (9)
Bone scan appearances following biopsy of bone and bone marrow. (1984) (9)
Correction to: 18F-NaF PET/CT: EANM procedure guidelines for bone imaging (2018) (9)
Re: Thyroid Carcinoma in an Autonomously Functioning Nodule (1980) (9)
Dual X-ray absorptiometry: clinical evaluation of a new cone-beam system. (2005) (9)
Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis (1993) (9)
Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation (2010) (9)
Screening for osteoporosis (1999) (9)
Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements (2004) (9)
The assessment of regional skeletal metabolism: studies of osteoporosis treatments using quantitative radionuclide imaging. (2011) (9)
Oral surgery: ARONJ masterclass (2014) (8)
Assessment of malignant and benign bone lesions by static F-18 Fluoride PET-CT: Additional value of SUV! (2008) (8)
Long term compliance with hormone replacement treatment following screening for postmenopausal osteoporosis by bone density measurements (1996) (8)
Dual X-ray Absorptiometry (2005) (8)
A Clinical Comparison of 99mTc-Hydroxyethylidene Diphosphonate (H.E.D.P.) and 99mTc-Pyrophosphate in the Detection of Bone Metastases (1977) (8)
Evaluation of Osteoporosis Using Skin Thickness Measurements (2007) (8)
Successful repeat transcatheter ablation of a mediastinal parathyroid adenoma 6 years after alcohol embolization (1997) (8)
Detection of an Elusive Osteoid Osteoma Using a Registration Bone Scan (1997) (8)
BONE MASS AFTER WITHDRAWAL OF OESTROGEN REPLACEMENT (1981) (8)
OD14 — Bone protection with no endometrial stimulation (1992) (8)
Thyroid function in normal pregnancy (1989) (8)
A direct in vivo measurement of 99mTc‐methylene diphosphonate protein binding (2003) (8)
Development of a phantom for morphometric X-ray absorptiometry. (2001) (8)
Bone Metastases: Diagnosis And Treatment (2012) (8)
Successful localisation of parathyroid adenomata by thallium-201 and technetium-99m subtraction scintigraphy: description of an improved technique (2004) (7)
Semiautomatic Region-of-Interest Validation at the Femur in 18F-Fluoride PET/CT (2012) (7)
99mTc-sestamibi and minimally invasive radioguided surgery for primary hyperparathyroidism. (2005) (7)
THE VALUE OF 24 HOUR SKELETAL UPTAKE OF DIPHOSPHONATE IN THE EXCLUSION OF METABOLIC BONE DISEASE (1980) (7)
The case for routine bone mass measurements. (1988) (7)
Evaluation of aortic 18F-NaF tracer uptake using PET/CT as a predictor of aortic calcification in postmenopausal women: A longitudinal study (2019) (7)
The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor. (1998) (7)
The role of bone density measurements in the evaluation of new treatments for osteoporosis. (2002) (7)
Bone single-photon emission tomography in recent meniscal tears: an assessment of diagnostic criteria (1993) (7)
Breast cancer and osteoporosis--a bridge at last. (1993) (7)
SPECT-CT in the assessment of bony foot pathology (2007) (7)
Bone scintigraphy in benign bone disease. (1984) (7)
Comparison of myocardial gated single photon emission computerised tomography, planar radionuclide ventriculography and echocardiography in evaluating left ventricular ejection fraction, wall thickening and wall motion (2004) (7)
Beware of the focal uptake at the ischium on the bone scan in prostate cancer (2011) (7)
Value of Lateral Blood Pool Imaging in Patients With Suspected Stress Fractures of the Tibia (2011) (7)
Screening for osteopenia and osteoporosis (1997) (7)
Clinical experience with etidronate in osteoporosis (1994) (6)
Pre-Operative Localisation of Parathyroid Tumours Using Neck Vein Catheterisation and Radioimmunoassay for Parathyroid Hormone: The Glasgow Experience (1983) (6)
(18)F-Fluoride PET in Osteoporosis. (2010) (6)
PET Imaging of the Skeleton (2006) (6)
Diagnostic Nuclear Medicine (2003) (6)
An Unexpected Change in DXA Calibration not Detected by Routine Quality Control Checks (1999) (6)
The flare phenomenon: still learning after 35 years (2010) (6)
The Bone Scan in Metabolic Bone Disease (1987) (5)
The time of day that etidronate is ingested does not influence its therapeutic effect in osteoporosis. (2000) (5)
92149358 Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis (1992) (5)
The future of bone density measurements (1997) (5)
Bone single photon emission computed tomography (2001) (5)
Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density (1999) (5)
Short communication: spinal bone density measured with a 5 s scan. (1993) (5)
Methods and Clinical Issues in Bone Densitometry (2008) (5)
Safety and efficacy of PTH(1-84) at 18 and 24 months in women with postmenopausal osteoporosis receiving hormone therapy: Results from the POWER study (2005) (5)
Concordance and precision of dual X-ray absorptiometry with a 10 s scan. (1996) (5)
Lesions in the ribs detected by bone scanning. (1980) (5)
Increase in bone mass after one year of percutaneous estradiol and testosterone implants in post‐menopausal women who have previously received long‐term oral estrogens (1993) (5)
OSTEOPOROSIS: A GROWING EPIDEMIC (1991) (5)
Clinical evaluation of a phalangeal bone mineral density assessment system. (2010) (4)
Improved lesion detection with dimethyl-amino-diphosphonate: A report of two cases (2004) (4)
Bone radionuclide imaging, quantitation and bone densitometry (2016) (4)
The Localisation of Parathyroid Tumours—A Comparison of Computed Tomography with Cervical Vein Hormone Assay (1983) (4)
Back pain: Can we make a contribution? (1997) (4)
Cyclical Etidronate Therapy for Prevention of Postmenopausal Bone Loss: A 1-Year Open-Label Follow-Up Study (2000) (4)
Focal osteomalacia due to “low dose” diphosphonate therapy in paget's disease (1984) (4)
Risedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass (1999) (4)
HL91, a new Tc-99m labelled agent with potential for identifying tumour hypoxia: Correlation with FDG PET (1996) (4)
Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton (1977) (4)
Bisphosphonates and vertebral fracture: An epidemiological perspective (2005) (4)
Facts and Artefacts in Bone Densitometry (2007) (4)
A39 Wrist registration scintigraphy: Use by specialist hand surgeons (2006) (4)
1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidism. (1979) (4)
Impact of bone mineral measurements on osteoporosis (2005) (4)
A Prospective Study of Risedronate on Regional Bone Metabolism and Blood Flow at the Lumbar Spine Measured by 18 F-Fluoride Positron (2003) (4)
Prevalence of inappropriate drug treatment in patients with hyperthyroidism. (1985) (4)
Effect of a GnRH analogue on bone mass in premenopausal patients with mastalgia (1993) (4)
Radioisotope and PET Imaging of Bone Metastases (2006) (4)
Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values. (1980) (4)
Glucocorticoids and æstrogens in the management of hypercalcaemia (1980) (4)
Ultrasonic velocity measurements through the calcaneus (1993) (4)
"Delta sign" in bone scan interpretation--a cautionary note. (1987) (4)
The Bone Scan in Paget’s Disease (1987) (4)
Bone densitometry and fracture risk prediction. (2004) (4)
Pagets disease of bone: Appearances with 18-FDG PET (1996) (4)
Relative Contribution of Humoral and Metastatic Factors to the Pathogenesis of Hypercalcaemia and Malignancy (1984) (3)
The Bone Scan—Historical Aspects (1987) (3)
3 Bone scanning and photon absorptiometry in metabolic bone disease (1988) (3)
Tampon-Associated Toxic Shock Syndrome—A Case Report (1981) (3)
Re: Mucociliary clearance mechanism in smoking and nonsmoking normal subjects. (1984) (3)
Anterior cruciate ligament tear: Findings on SPET bone scintigraphy of the knee (1995) (3)
Osteosarcomatous metaplastic carcinoma of the breast with metaplastic changes seen in lymph node metastasis: A case history and review of imaging findings (2008) (3)
Clinical experience with etidronate (1993) (3)
Sacroiliac steroid injections do not predict ablation relief-not a surprise. (2013) (3)
Chapter 32. Radionuclide Scintigraphy in Metabolic Bone Disease (2009) (3)
Oat cell carcinoma of bronchus presenting as an acute psychiatric illness in young women (1982) (3)
SPET bone scanning can predict successful facet joint injection (1995) (3)
Interesting Signs in Nuclear Medicine. (2015) (3)
Bone densitometry, steroids and osteoporosis (2003) (3)
Bone Secondariesin BreastCancer: The SolitaryMetastasis (1989) (3)
Strontium does accumulate in bone (2012) (3)
Technetium-thallium subtraction images for location of parathyroid adenomata. (1984) (3)
A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration (2007) (2)
Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism. (1977) (2)
Post-menopausal vertebral osteoporosis (1994) (2)
Pseudo pulmonary embolism in complex congenital heart disease. (1996) (2)
Comprar An Atlas Of Clinical Nuclear Medicine | Fogelman, I. | 9781841846538 | CRC PRESS (2013) (2)
A clinical comparison of 2 h and 4 h bone scans obtained with 99mTc H.E.D.P. (2004) (2)
99mTc Diphosphonate Bone-scanning Agents (1987) (2)
Comparison of myocardial gated spect, planar radionuclide ventriculography and echocardio-graphy in evaluating left ventricular ejection fraction, wall motion and thickening (2004) (2)
Insulin-like growth factor (IGF)-I levels in postmenopausal women receiving tibolone. (1995) (2)
1, 2, 3, or 4 phase bone imaging--how many are necessary? (1990) (2)
Hybrid Imaging in the Management of Complex Foot and Ankle Problems (2012) (2)
Intervertebral T-score differences in younger and older women. (2013) (2)
19. Bone SPECT in patients with back or knee pain: A review of 640 cases (1993) (2)
79. Supine lateral is a superior technique to decubitus lateral for dual X-ray absorptiometry studies of the lumbar spine (1993) (2)
A pilot study to evaluate the relationship between F-18-fluoride positron emission tomography measurements of bone turnover at the lumbar spine with changes in BMD (2006) (2)
Minimum effective dose of estrogen for protection against post menopausal bone loss (1982) (2)
Controversies in nuclear medicine. Investigation of the solitary thyroid nodule. (1989) (2)
Quantitative studies of bone using 18F-flouride and 99mTc-methylene diphosphonate. (2001) (2)
Monitoring skeletal response to treatment which site to measure in the femur? (2000) (2)
59. Patient dosimetry studies on the hologic QDR-1000 and QDR-1000/W (1992) (2)
Radionuclide Scintigraphy in Metabolic Bone Disease (2013) (2)
The precision of F-18-fluoride positron emission tomography as used to measure regional bone turnover at the spine and hip (2006) (2)
Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer. (1988) (2)
A comparison of regional bone turnover at the spine and hip in postmenopausal women with osteoporosis (2004) (2)
CAPD fluid: A common cause of photon deficient lesions on99mTc-D.T.P.A. scans in renal transplant patients (2004) (2)
The effect of season and vitamin D supplementation on bone mineral density: A double-blind cross-over study (2000) (2)
Osteoporosis: the clinical problem. (1986) (2)
Updated survival results from the Zebra trial. (2002) (2)
Osteoporosis, bone mineral measurements and photon absorptiometry. (1985) (2)
Fracture thresholds in osteoporosis (1992) (2)
Prevalence of inappropriate drug treatment in patients with hyperthyroidism (1986) (2)
Yield of FDG-PET scanning as a routine follow-up exam in patients with malignancy. (2000) (2)
Comparison of ordered-subset expectation maximization and filtered back projection reconstruction based on quantitative outcome from dynamic [18F]NaF PET images (2021) (2)
Bone scanning and photon absorptiometry in metabolic bone disease. (1988) (2)
Single Photon Emission Computed Tomography and the Source of Lumbar Pain in Advanced Ankylosing Spondylitis (1995) (2)
Densitometry and bone mineral measurement. (1990) (1)
Hybrid SPECT/CT imaging - A significant advance in the assessment of painful hip and knee post-arthroplasty (2014) (1)
A single plasma sample method to assess disease activity in patients with bone metastases from carcinoma of the prostate. (1986) (1)
Diphosphonates in the evaluation of metabolic bone disease (1982) (1)
Recent advances in bone densitometry (1993) (1)
Thiazide diuretics and osteoporosis (1991) (1)
The Effect of Accuracy Errors On The Clinical Interpretation Of DXA Scans (2008) (1)
P2. The value of bone scintigraphy in the evaluation of osteoporotic patients with back pain (2000) (1)
YOUNG INVESTIGATOR AWARD) THE ANABOLIC EFFECT OF TERIPARATIDE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS MEASURED USING NUCLEAR SCINTIGRAPHY (2010) (1)
Isotope imaging. (1996) (1)
Tibolone, a form of HRT without the need for withdrawal bleeding prevents postmenopaubal bone loss (4 years follow-UP) (2006) (1)
In-vivo cross-calibration of a new peripheral densitometer: The Osteometer Dexacare G4. (2003) (1)
PET and bone metastases (2005) (1)
Bone Densitometry, X-Ray and Quantitative Ultrasound (1998) (1)
Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness (2012) (1)
Osteopetrosis: Radiological and Radionuclide Imaging (1)
Bone scanning in the 90s: improving your diagnostic yield and specificity with SPECT (1995) (1)
What do we want from a bone-scanning agent? (1980) (1)
The heritability of SOS and BMD - a comparative study between multi-site ultrasound and DXA: A twin study. (2000) (1)
Bone scan appearances following bone and bone marrow biopsy (1984) (1)
The Measurement of Bone Density (1990) (1)
Radionuclide Imaging of the Hand and Wrist (2013) (1)
Negative F-18 Fluoride PET in malignant sclerotic bone lesions: Therapeutic effect, apoptosis, false negative? (2008) (1)
Nuclear medicine: a clinical service. (1985) (1)
Bone densitometry: an update References for figures (2005) (1)
The ZEBRA study: Reversibility of bone mineral density of pre-/perimenopausal patients with node-positive early breast cancer after treatment with Zoladex™ (2001) (1)
18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease (2013) (1)
Overview of the Role of Bone Scintigraphy in the Pathophysiology of Sporting Injuries (2015) (1)
Where now for the management of osteoporosis? (2005) (1)
Overestimation of true renal clearance by conventional measurements of GFR using Cr-51-EDTA - Reply (2003) (1)
Polymorphisms in the P450C17 (17-hydroxylase/17,20-lyase)and P450C19 (aromatase) genes: Assosiation with serum sex steroids concentrations and bone mineral density in postmenopausal women (2003) (1)
PP.24.09: A PILOT STUDY TO ASSESS EFFECTS OF ALENDRONIC ACID ON AORTIC CALCIFICATION AND STIFFNESS IN POSTMENOPAUSAL WOMEN (2015) (1)
Bone density measurements and therapeutic decision making. (1998) (1)
Benign and Malignant Bone Disease: A Clinician??s Guide to Nuclear Medicine (1992) (1)
Direct labelling via simultaneous reduction of pertechnetate and a disulfide bond. (2002) (1)
4. Comparison of simultaneous 99TcmHMPAO- and 111In-labelled white cell scans in assessment of inflammatory bowel disease (1990) (1)
92312604 Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens (1993) (1)
Wrist Registration: Conventional Radionuclide and SPECT/CT Imaging (2012) (1)
Biochemical assessment predicts radiological response in bone metastases from breast cancer (1987) (1)
Rickets in a white adolescent (1979) (1)
91. 18FDG PET in Pagetʼs disease of bone (1994) (1)
Risedronate is well-tolerated in women with osteoporosis (1999) (1)
Quantitative dynamic bone SPECT: A new method to assess skeletal kinetics. (2003) (1)
Reproducibility of visual vertebral deformity assessment on lateral X-ray absorptiometry scans and conventional radiographs of the spine. (2000) (1)
Bone scanning in metabolic and endocrine bone disease. (1989) (0)
Book reviewsThyroid Diseases (Nuclear Medicine & Biology Advances. Vol. V). Ed by BeckersChristian, pp. 227, 1983 (Pergamon Oxford). (1984) (0)
PATHOGENESIS OF OSTEOPOROSIS (1980) (0)
A new tracer test of skeletal function (1999) (0)
Pitfalls and Limitations of Radionuclide and Hybrid Imaging: Part 2. (2015) (0)
Prevalence of inappropriate drug treatment in patients with hyperthyroidism (1986) (0)
The effects of exercise training on bone mineral accumulation in adolescent girls. (2000) (0)
Can dual-energy x-ray absorptiometry-based hip structural analysis be used in patients treated with strontium ranelate? (2012) (0)
Oatcell carcinoma ofbronchus presenting asanacute psychiatric illness inyoung women (1982) (0)
Letter from the Guest Editor: Pitfalls and Limitations of Radionuclide and Hybrid Imaging--Part I. (2015) (0)
Ageâ€"Related Alterationsin Skeletal Metabolismâ€"24@hr Whole-BodyRetention of Diphosphonate in 250 NormalSubjects:ConciseCommunication (1982) (0)
“Low dose” disodium etidronate causes intermittent inhibition of bone mineralization and focal osteomalacia in Paget's disease (1985) (0)
PERIPROSTHETIC BONE REMODELLING OF TWO HA-COATED FEMORAL IMPLANTS: A 3-YEAR FOLLOW-UP STUDY ADDRESSING THE INFLUENCE OF PROSTHETIC DESIGN AND BONE QUALITY ON POSTOPERATIVE BONE LOSS (2006) (0)
The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats (2004) (0)
Caclaneal bua changes in a 2 year placebo controlled study of pamidronate in post menopausal osteoporosis (2006) (0)
Current pain and the visual analogue scale as a predictor of quality of life in individuals with osteoporosis (2006) (0)
Investigation of Metabolic Bone Diseases (Section Editor: Pierre Delmas) (2008) (0)
87. Radiographer dose in dual-energy X-ray absorptiometry: A comparison with gamma camera and PET scanning (1996) (0)
Differential effects of multi-site SOS and DXA on cortical bone with HRT. (2001) (0)
A method for determining skeletal ratios from DXA images (2006) (0)
Conventional Nuclear Medicine and Hybrid Imaging in Monitoring the Treatment of Skeletal Malignancy (2012) (0)
Predicting the risk of fracture at any site in the skeleton: Are all BMD measurements equally effective? (2004) (0)
Stimulators of bone formation (2000) (0)
Bone turnover at the spine and hip measured using 18F-PET (2011) (0)
58. Comparison between three-phase and two-phase bone scintigrams for bone pathology (1992) (0)
(Young Investigator Award) - Direct assessment of regional osteoblastic activity in the spine pre and post 6 months of risedronate as measured by 18F-fluoride positron emission tomography (2003) (0)
Bone density screening for osteoporosis (1990) (0)
14. 153Sm-EDTMP for the treatment of patients with painful bone metastases (1994) (0)
A simple noninvasive method for assessing renal osteodystrophy. (1987) (0)
A method for determining skeletal ratios from DXA scans (2005) (0)
Comparison of the pharmacokinetics of 14C-labelled APD and 99m Tc-labelled APD in the mouse (1989) (0)
82. The evaluation of a new two-headed detector tomographic gamma camera (IGE Maxxus) in a clinical environment (1994) (0)
Improvement in nutrition reduces bone resorption in elderly women with osteoporosis and low body mass index : A randomised controlled trial. (2002) (0)
Letter to the editor (2006) (0)
Painful and/or swollen joint (2003) (0)
P41. 22 years of nuclear medicine history from a teaching hospital department (2000) (0)
Serum Osteoprotegerin (OPG): Development and clinical application of an enzyme linked immunosorbent assay. (2003) (0)
Renal excretion of technetium-99m diphosphonate in osteomalacia. (1979) (0)
Book reviewsRadionuclide Imaging of the Brain. By HolmanB. Leonard, pp. xiv + 232, 1985 (Churchill Livingstone, New York), £60.00. ISBN 0–443–08348–7 (1986) (0)
Can the combination of two BMD measurements ever improve fracture discrimination (2002) (0)
28. Comparison of analytical methods for measuring skeletal kinetics with dynamic 18F-fluoride PET (2001) (0)
Updated survival analyses from the ZEBRA study: goserelin vs CMF in premenopausal women with node-positive breast cancer (2003) (0)
F-NAF TRACER UPTAKE DETECTED USING PET/CT IN PREDICTING AORTIC CALCIFICATION OVER A 4-YEAR FOLLOW-UP PERIOD (0)
Analysis of Hip Scans On Hologic DXA Systems (2008) (0)
Are liver metastases involved in the pathogenesis of hypercalcaemia of malignancy (HM) (1987) (0)
Evaluation of aortic 18F-NaF tracer uptake detected using PET/CT in predicting aortic calcification over a 4-year follow-up period (2015) (0)
Calcaneal quantitative ultrasound and clinical risk factors for osteoporosis. (2000) (0)
28. Spine and femur BMD in varying severity spinal osteoporosis (1993) (0)
Effect of sodium etidronate and phenytoin on Pagetic bone. (1982) (0)
PET in malignancy of the skeleton (2005) (0)
Chest pain in patients with normal coronary arteriograms (1984) (0)
Bone densitometry. Can predict those at high risk of fractures. (1994) (0)
Bone scintigraphy. II: Orthopedic bone scanning (1993) (0)
Do vertebral deformities in the lumbar spine affect BMD measured by DXA (2000) (0)
DOPE TESTS FOR DOCTORS? (1980) (0)
Sex hormone and adrenal androgen concentrations in men with idiopathic and steroid-induced osteoporosis. (2001) (0)
THE RELATIONSHIP BETWEEN AORTIC STIFFNESS AND ABDOMINAL AORTIC CALCIFICATION MEASURED ON SPINE DXA VFA SCANS IN POSTMENOPAUSAL WOMEN (2012) (0)
81. The significance of lumbar spine BMD heterogeneity (1993) (0)
Skeletal scintigraphy and quantitative tracer studies in metabolic bone disease (1982) (0)
Arterial stiffness and carotid wall characteristics in post-menopausal women with and without osteoporosis (2005) (0)
Is axial transmission ultrasound sensitive to risk factors for osteoporosis (2004) (0)
BMD changes up to 3 years following treatment with Zoladex or CMF in pre-/perimenopausal women with early breast cancer participating in the ZEBRA study. (2001) (0)
45. Quantification of skeletal kinetic indices in Pagetʼs disease using dynamic 18F-fluoride PET (2001) (0)
Whole Body 18 F-Fluoride Pet Measurements Of Regional Bone Metabolism (2012) (0)
P40 Facts and artefacts in dual energy X-ray absortiometry (2006) (0)
Corrigendum to “Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)” [Bone 48 (2011) 1127–1132] (2011) (0)
Nuclear medicine in clinical practice : 100 self-assessment case studies (1997) (0)
Low bone density is a major risk factor for periprosthetic bone loss following total hip arthroplasty. (2002) (0)
P2. Validation of ultrafiltration as a method of measuring protein binding of 99mTc-MDP (2002) (0)
(Young Investigator Award) - Does combining sites improve fracture discrimination? (2003) (0)
Is IVA a reliable method of detecting vertebral fractures (2006) (0)
Comparison of analytical methods for measuring regional skeletal kinetics with dynamic F-18-fluoride PET (2001) (0)
Differential Effects Of Teriparatide On Trabecular And Cortical Bone Measured By 18 F-Fluoride Positron Emission Tomography (2012) (0)
21. A comparison of MRI and bone SPECT in the diagnosis of chronic knee pain (1993) (0)
The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants (1991) (0)
57. SPECT bone imaging of the knees - a comparison with arthroscopic findings (1992) (0)
Referral patterns for men to an osteoporosis scanning service from family practitioners (2005) (0)
Detecting Bone Size Quantitative Trait Loci Using DXA Imaging (2007) (0)
Potential Applications and Limitations of SPECT-CT in Classifying Bone Lesions in Patients with Cancer (2012) (0)
PL7.2. PET and bone metastases (2008) (0)
Radionuclide imaging techniques in the evaluation of metabolic bone diseases (1998) (0)
The safety and efficancy of PTH in women receiving hormone therapy. (2005) (0)
Doses to nurses from the treatment of thyroid cancer patients with an ablative dose of 131I (1993) (0)
The 'in vivo' gene expression changes of RANKL/OPG/RANK in human mononuclear cells following treatment with estrogen or Raloxifene : Possible role in the reduction in bone resorption. (2003) (0)
THE PREVALENCE OF ABDOMINAL AORTIC CALCIFICATION ASSESSED USING LATERAL VERTEBRAL FRACTURE ASSESSMENT DXA SCANS IN POSTMENOPAUSAL WOMEN WITH AND WITHOUT OSTEOPOROSIS (2009) (0)
Combining sites for fracture discrimination: results for axial transmission ultrasound compared with a theoretical model. (2003) (0)
P38 Case report: branching (atypical) Paget??s disease of bone (2006) (0)
7. The interpretation of bone SPECT lesions in chronic back pain using X-rays and computed tomography (1990) (0)
Dissecting RoomBooks in briefBooks in brief, Glen M Blake, Heinz W Wahner, Ignac Fogelman, Martin Dunitz, London (1999), Pp 470. £75, ISBN: 1-85317-472-6 (1999) (0)
Medicine moves forward at a rapid pace in the field of imaging. (2009) (0)
Nuclear Medicine Annual 2003 (2004) (0)
Bone health in breast cancer survivors following adjuvant bisphosphonate therapy: AZURE quantitative bone scan sub-study (2011) (0)
Another look. at hypercalcemia of malignancy (1983) (0)
Can the WHO criteria be applied to multi-site axial transmission quantitative ultrasound? (2002) (0)
Rickets inawhite adolescent (1979) (0)
86. The effect of weight change on DXA scans (1997) (0)
Comprar Atlas of clinical pediatric nuclear medicine | Ignac Fogelman | 9780340885178 | Hodder Arnold (2010) (0)
Bone scintigraphy. I: Oncology and infection (1993) (0)
Nuclear medicine in radiological diagnosis (2003) (0)
25. Conventional measurements of renal function using 51Cr-EDTA overestimate true GFR by 10% (2002) (0)
Insulin like Growth Factor, (IGF1) and Bone Mineral Density (1995) (0)
44. A lysine-to-arginine substituted analogue of salmon calcitonin for site-specific radiolabelling (2002) (0)
Bone Spect Case Studies (1990) (0)
A cost-effectiveness analysis of the use of bisphosphonate therapy among elderly women (1992) (0)
Comparison of skeletal uptakes of three diphosphonates by whole-body retention. [Technetium 99] (1981) (0)
The effect of etidronate disodium on skeletal metabolism following the menopause (1987) (0)
Estrogen and Raloxifene modulate the expression of osteoprotegerin (OPG) and RANK-ligand (RANKL) in human osteoblast-like cells at supra-physiological/pharmacological concentrations. (2001) (0)
A Clinical Comparison of Tcâ€”99m HEDP and Tcâ€”99m MDP (2006) (0)
The individual risk of osteoporosis: advances in the use of techniques for the identification of high risk groups within the general population and identification of the individual with active dissease (2001) (0)
99mTc-MDP bone SPECT/CT applications & scan appearances in ankle/foot pain: Pre and post-operative scenario (2015) (0)
Clinical comparison of /sup 99m/Tc HEDP and /sup 99m/Tc MDP in the detection of bone metastases: concise communication. [Comparative effectiveness of 2 phosphoric acid ster radiopharmaceuticals] (1979) (0)
The Evaluation of Vertebral Fracture Assessment and Pulse Wave Velocity for the Assessment of Abdominal Aortic Calcification by Comparison to Computed Tomography (2018) (0)
35. 11C-methionine PET for patients with persistent or recurrent hyperparathyroidism after surgery (1996) (0)
[Nuclear medicine technics in the study of bone metabolic diseases]. (1980) (0)
RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene: Potential role in post-menopausal osteoporosis (2004) (0)
SERUM CONCENTRATIONS OF VITAMIN E ISOFORMS AND BONE TURNOVER IN POST-MENOPAUSAL WOMEN (2014) (0)
35. The use of FDG PET as a ‘metabolic biopsy’ for non-lung tumours (2000) (0)
Bone Scanning and 24-Hour Whole Body Retention of Diphosphonate in the Evaluation of Metabolic Bone Disease (1981) (0)
Skeletal Tracer Kinetics: Science and Practice (2012) (0)
Risedronate is effective in preventing first vertebral fracture in women (2001) (0)
Bone and soft tissue tumors (2007) (0)
A comparative study of F-18 FDG and C-11 Methionine PET in the evaluation of brain tumours (2002) (0)
The 'metabolic biopsy': Dedicated FDG-PET for failed biopsy in non-lung lesions. (2000) (0)
The treatment of osteoporosis. (2001) (0)
In-vivo cross-calibration of a new peripheral DXA densitometer. (2001) (0)
Advances in the prevention of osteoporosis. (1989) (0)
Diabetes and bone (2009) (0)
71. No more volumes of distribution (1997) (0)
The investigation of soft tissue disorders: nuclear medicine (2004) (0)
Aromatase gene polymorphisms Association with bone mineral density and serum estradiol concentrations in post-menopausal women (2002) (0)
86. Is lateral DXA superior to posteroanterior scanning for monitoring the response of patients treated for osteoporosis (1996) (0)
The interpretation of DXA scans in patients taking strontium ranellate treatment (2006) (0)
A comparison of one and two day protocols for ferforminc Tc99mTetrofosmine myocardial studies (1995) (0)
Soft Tissue Uptake in Radionuclide Bone Scintigraphy (2012) (0)
Impact of 99mTc-MDP SPECT/CT in postoperative arthrodeses of the feet: A step ahead (2011) (0)
Effect of hormone replacement therapy on serum angotensin I-converting enzyme (1995) (0)
Books in brief Glen M Blake Heinz W Wahner (1999) (0)
The Clinical Relevance of Bone Mass Measurements (1990) (0)
Book reviewsContemporary Issues in Nuclear Imaging. Radionuclide Bone Imaging and Densitometry. By MettlerFred A.Jr, pp. ix + 342, 1988 (Churchill Livingstone, New York), £53.00. ISBN 0–443–08546–3 (1989) (0)
Positron Emission Tomography - Clinical Practice (2006) (0)
85. Long-term precision of DXA scanning assessed in 40 early post-menopausal women followed over 7 years (1997) (0)
A simple blood sampling method of measuring bone turnover: validation (2004) (0)
Multimodality multiparametric assessment of bone metastases in prostate and breast cancer: 18F-Fluoride, 11C-Choline, 18F-FDG PET/CT and DW-MRI (2014) (0)
F086 The effect of six years nonbleeding HRT (tibolone) on the female skeleton (1996) (0)
Differences in skeletal kinetics between trabecular and cortical sites measured by F-18-fluorine positron emission tomography (2000) (0)
SCINTIGRAPHY, X-RAYS, AND METASTATIC BREAST CANCER (1983) (0)
P065 Five years therapy of HRT and the effect on body mass index (1996) (0)
Problematic back pain in osteoporosis: Bone scintigraphy, the diagnostic solution? (2000) (0)
20. Spinal bone density measured with a 5 s scan (1992) (0)
Bone Mineral Density, Arterial Calcification and atherosclerosis in postmenopausal women (2006) (0)
Another Look at the Pathogenesis of Malignancy Associated Hypercalcaemia (1983) (0)
Estimation of Skeletal Involvement in Primary Hyperparathyroidism (2020) (0)
Calcaneal quantitative ultrasound and clinical risk factors for low BMD (2000) (0)
Abstracts of original contributions ASNC 2004 9th annual scientific session September 3-–October 3, 2004 New York, New York (2004) (0)
Bone infection. (2010) (0)
Osteopenia in anorexia nervosa: The effect of recovery (1987) (0)
Visibility of thoracic vertebra using instant vertebral assessment is dependent on hip boone mineral density (2006) (0)
Thiazide diuretics and osteoporosis. (1991) (0)
The effect of progestagens and tibolone on bone (1993) (0)
Author's reply (1993) (0)
The â€œHotPatellaâ€ • Sign : Is Itof AnyClinicalSignificance ? Concise Communication (2006) (0)
Quantification of skeletal kinetic indices in Paget's disease using dynamic F-18-fluoride PET (2001) (0)
Pregnancy inawomanwith premature ovarian failure (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ignac Fogelman?

Ignac Fogelman is affiliated with the following schools: